Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dierk Thomas

Showing results (111-120 of 212) with videos related to

Pageof 22
Sort By:
Journal of Thoracic Disease|February 8, 2020
Risk factors and survival of patients with permanent pacemaker implantation after heart transplantationRasmus Rivinius, Matthias Helmschrott, Ann-Kathrin Rahm, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 4, 2017
Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heartRasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, et al.
Journal of Electrocardiology|January 26, 2016
Catheter ablation of atrial fibrillation in patients with concomitant sinus bradycardia-Insights from the German Ablation RegistryMaura M Zylla, Johannes Brachmann, Thorsten Lewalter, et al.
Biochemical and Biophysical Research Communications|September 5, 2019
The C-terminal HCN4 variant P883R alters channel properties and acts as genetic modifier of atrial fibrillation and structural heart diseaseIsabel Weigl, Pascal Geschwill, Miriam Reiss, et al.
Biochemical and Biophysical Research Communications|July 4, 2012
Inhibition of cardiac Kir2.1-2.3 channels by beta3 adrenoreceptor antagonist SR 59230AMartin Kulzer, Claudia Seyler, Florian Welke, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 24, 2006
Orange flavonoid hesperetin modulates cardiac hERG potassium channel via binding to amino acid F656Eberhard P Scholz, Edgar Zitron, Claudia Kiesecker, et al.
The American Journal of Cardiology|January 17, 2015
Prevalence of intracardiac thrombi under phenprocoumon, direct oral anticoagulants (dabigatran and rivaroxaban), and bridging therapy in patients with atrial fibrillation and flutterMaura M Zylla, Mara Pohlmeier, Alexander Hess, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 19, 2024
Use of class IC antiarrhythmic drugs in patients with structural heart disease and implantable cardioverter defibrillatorMaura M Zylla, Julian Wolfes, Ruben Schleberger, et al.
Plos One|May 24, 2016
Inhibition of Cardiac Kir Current (IK1) by Protein Kinase C Critically Depends on PKCβ and Kir2.2Daniel Scherer, Claudia Seyler, Panagiotis Xynogalos, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 25, 2019
Digitalis therapy is associated with higher comorbidities and poorer prognosis in patients undergoing ablation of atrial arrhythmias: data from the German Ablation RegistryGerrit Frommeyer, Johannes Brachmann, Hüseyin Ince, et al.
Pageof 22

Showing results (111-120 of 212) with videos related to

Sort By:
Pageof 22
Journal of Thoracic Disease|February 8, 2020
Risk factors and survival of patients with permanent pacemaker implantation after heart transplantationRasmus Rivinius, Matthias Helmschrott, Ann-Kathrin Rahm, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 4, 2017
Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heartRasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, et al.
Journal of Electrocardiology|January 26, 2016
Catheter ablation of atrial fibrillation in patients with concomitant sinus bradycardia-Insights from the German Ablation RegistryMaura M Zylla, Johannes Brachmann, Thorsten Lewalter, et al.
Biochemical and Biophysical Research Communications|September 5, 2019
The C-terminal HCN4 variant P883R alters channel properties and acts as genetic modifier of atrial fibrillation and structural heart diseaseIsabel Weigl, Pascal Geschwill, Miriam Reiss, et al.
Biochemical and Biophysical Research Communications|July 4, 2012
Inhibition of cardiac Kir2.1-2.3 channels by beta3 adrenoreceptor antagonist SR 59230AMartin Kulzer, Claudia Seyler, Florian Welke, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 24, 2006
Orange flavonoid hesperetin modulates cardiac hERG potassium channel via binding to amino acid F656Eberhard P Scholz, Edgar Zitron, Claudia Kiesecker, et al.
The American Journal of Cardiology|January 17, 2015
Prevalence of intracardiac thrombi under phenprocoumon, direct oral anticoagulants (dabigatran and rivaroxaban), and bridging therapy in patients with atrial fibrillation and flutterMaura M Zylla, Mara Pohlmeier, Alexander Hess, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 19, 2024
Use of class IC antiarrhythmic drugs in patients with structural heart disease and implantable cardioverter defibrillatorMaura M Zylla, Julian Wolfes, Ruben Schleberger, et al.
Plos One|May 24, 2016
Inhibition of Cardiac Kir Current (IK1) by Protein Kinase C Critically Depends on PKCβ and Kir2.2Daniel Scherer, Claudia Seyler, Panagiotis Xynogalos, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 25, 2019
Digitalis therapy is associated with higher comorbidities and poorer prognosis in patients undergoing ablation of atrial arrhythmias: data from the German Ablation RegistryGerrit Frommeyer, Johannes Brachmann, Hüseyin Ince, et al.
Pageof 22